Menu

Antibiotics and the Gut Microbiome

Antibiotics given to infant mice may have long-term effects on the animals’ metabolism and gut microbiota. 

Jun 30, 2015
Anna Azvolinsky

WIKIMEDIA, SAGE ROSSEven short pulses of widely used antibiotics can lead to long-term development changes in mouse pups, including increased body mass and bone growth and changes to the gut microbiota, according to a study published today (June 30) in Nature Communications.

“While this is a correlative study, [the researchers] present a plausible case that antibiotics, by changing the gut microbiota, may affect host function,” said Lee Kaplan, a gastroenterologist and molecular biologist at the Massachusetts General Hospital in Boston who was not involved in the work. “This suggests there may be correlates between the microbiota and changes in the host that can be identified in future experiments and exploited for therapeutic benefit.”

In prior studies, microbiologist Martin Blaser of the New York University Langone Medical Center and his colleagues showed that mice given low-doses of penicillin shortly after birth became overweight in adulthood if fed a high-fat diet, and that this effect was due to changes in the gut microbiota and metabolism. Seeing profound changes with even low-dose antibiotic exposure—similar to the chronic antibiotic treatment of farm animals to promote growth—Blaser wanted to understand the effects of therapeutic antibiotic doses in kids. “Children don’t get low-dose antibiotics every day, they get pulses of high doses of antibiotics for short time periods to treat infections,” he said.

To replicate this in the lab, the researchers gave three short doses of amoxicillin or another antibiotic called tylosin, or alternating courses of each. Amoxicillin is the number one prescribed pediatric antibiotic, according to Blaser, while macrolides like tylosin are the second most frequently used antibiotics class. The mice also received a high-fat diet several days after the antibiotic treatment, which Blaser suspects exacerbates the metabolic phenotype associated with antibiotics.

As Blaser’s group anticipated, the antibiotic treatments resulted in notable changes to the gut microbiota of the mice, although the two antibiotics resulted in different patterns. Tylosin treatment resulted in changes to the gut microbes that lasted for several months, for example, while amoxicillin treatment led to shorter-term changes that only lasted a week. Tylosin and the combined-antibiotic treatment also seemed to have a greater impact on Bacteroidetes species than amoxicillin treatment alone.

“This is a very nice work and it is bold—using high-fidelity shotgun metagenomics in an animal intervention model,” added Kristoffer Forslund a research scientist at the European Molecular Biology Laboratory, Heidelberg, Germany who was also not involved in the study. “Few have done that on this scale, which makes this a milestone.”

The antibiotic treatments also affected the animals’ fat and bone-density levels. Amoxicillin treatment resulted in increases in lean mass and significantly larger bones and higher bone mineral content while tylosin increased lean and total body mass compared to no antibiotic control animals. “This means that the antibiotics are affecting early life development,” said Blaser. Pulsed antibiotic treatment also resulted in gene expression changes in the liver as many as 120 days after completion of the treatment.

“These are important observations that need to be replicated in human studies,” Willem de Vos, a microbiologist at Wageningen University in the Netherlands told The Scientist in an e-mail. While previous work has shown that microbial communities influence obesity and insulin resistance, this study supports the idea that antibiotics affect the gut microbiome and that the disturbed gut microbiota may contribute to metabolic signaling.

“[This study] underscores the complexity of the system and the need to continue to drill more deeply,” said Kaplan. (To read more about the importance of the microbiome in health and disease, read this month’s feature story, “The Sum of Our Parts.”)

Y.R. Nobel et al. “Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment,” Nature Communications, doi:10.1038/ncomms8486, 2015.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!